We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ANFO.SW

Price
102.80
Stock movement down
-0.20 (-0.19%)
Company name
UBS (CH) PF Swiss Residential Ord
Exchange
(SW
,
Currency
CHF
)
Market cap
-
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
10.32%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-31

DIVIDENDS

ANFO.SW does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open102.60
Daily high102.80
Daily low101.60
Daily Volume15K
All-time high102.80
1y analyst estimate-
Beta-
EPS (TTM)-
Dividend per share0.00
Ex-div date26 Nov 2024
Next earnings date-

Downside potential

Loading...
Downside potential data
ANFO.SWS&P500
Current price drop from All-time high-0.59%-
Highest price drop-7.21%-19.00%
Date of highest drop9 Apr 20258 Apr 2025
Avg drop from high-2.70%-2.76%
Avg time to new high38 days5 days
Max time to new high195 days89 days
COMPANY DETAILS
ANFO.SW (UBS (CH) PF Swiss Residential Ord) company logo
Marketcap
-
Marketcap category
Mid-cap
Description
Employees
Website
Investor relations
-
CEO
Country
Switzerland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The cider brand has added a high-contrast NaviLens QR code to its cans.
September 9, 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
September 9, 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
September 9, 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
September 9, 2025
Novartis agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted therapy drug pacibekitug. The Swiss pharmaceuti...
September 9, 2025
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmali...
September 9, 2025